Valion Bio said it issued a press release about its wholly owned subsidiary, but the announcement's details are not included. The filing alone does not show a change to Valion Bio's outlook.
There is no clear change to Valion Bio's business outlook because the report does not say what its subsidiary announced. It confirms a press release exists, but the release's details are missing from the supplied text.
Follow Valion Bio, Inc. (VBIO) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for VBIO